Changes in company's own shares

December 29, 2025 14:40 ET | Source: Alvotech Alvotech

Attached is a filing with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) regarding changes in company's own shares.

Attachment

Alvotech Own Shares Notification 29 Dec 2025

Attachments

Alvotech Own Shares Notification 29 Dec 2025

Alvotech Own Shares Notification 29 Dec 2025...

Recommended Reading

August 21, 2026 09:00 ET | Source: Alvotech

Alvotech Announces Licensing and Commercialization Agreement with Lotus Pharmaceutical for proposed biosimilars to durvalumab and emicizumab in the U.S. and Selected Asian Markets

REYKJAVIK, Iceland, Aug. 21, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for...
Read More
August 21, 2026 09:00 ET | Source: Alvotech

Alvotech Announces Licensing and Commercialization Agreement with Lotus Pharmaceutical for proposed biosimilars to durvalumab and emicizumab in the U.S. and Selected Asian Markets

REYKJAVIK, ICELAND (August 21, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide,...
Read More